Brief report · 30 Jun 2026
Conference abstractPublished 2 Oct 2017
Novel quinazoline derivative as RAF Inhibitor
Development Center for Biotechnology, Institute of Pharmaceutics, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The oncogenic mutations of BRAF, occur most frequently in V600E, leading to constitutive activation of the MAPK signaling pathway, are common in a variety of human cancers. Recently, drugs targeting RAF kinase have been approved as an effective treatment for human malignancies that rely on this target for their growth. Thus, suppressing RAF kinase activity is a clinically meaningful approach in cancer patients harboring RAF driven oncogene. In this study, a series of quinazoline derivative was synthesized and evaluated for their RAF kinases inhibition activity. Several potent compounds displayed double-digit nanomolar IC50 values for RAF kinases including CRAF, BRAF, and BRAFV600E. Preliminary profiling of one of the most active compounds in a panel of protein kinases revealed its selectivity for RAF kinases. In cells, the compound exhibited selective cytotoxicity against cancer cells harboring BRAF V600E mutation and dose-dependent inhibition of the phosphorylation of RAF downstream effectors MEK and ERK. Moreover, the compound was oral active in mice bearing A375 BRAFV600EâÂ?mutant melanoma xenograft. Therefore, the novel quinazoline derivative proved to be active as RAF inhibitor.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shih-Chieh Yen”
- BylineArticles whose byline prints “Chu-Bin Liao”
- BylineArticles whose byline prints “Hung-Jyun Huang”
- BylineArticles whose byline prints “Ju-Ying Yang”
- BylineArticles whose byline prints “Yen-Hsi Liu”
- BylineArticles whose byline prints “Sian-Yi Ciou”
- BylineArticles whose byline prints “Mann-Yan Kuo”
- BylineArticles whose byline prints “Shao-Zheng Peng”

